Literature DB >> 9769272

Impaired perception of dyspnea in patients with severe asthma. Relation to sputum eosinophils.

J C Veen1, H H Smits, A J Ravensberg, P S Hiemstra, P J Sterk, E H Bel.   

Abstract

Poor dyspnea perception might be a risk factor for developing asthma exacerbations. We investigated whether severe asthmatics with recurrent exacerbations (brittle asthma) have different dyspnea perception and sputum cells compared with equally severe, but stable asthmatics, or patients with mild steroid-naive asthma. Fifteen brittle asthmatics (13 female, median age 28 yr [range, 20 to 47 yr]), 15 matched severe-stable asthmatics (14 female, median age 26 yr [range, 17 to 52 yr]), and 11 mild asthmatics (8 female, median age 25 yr [range, 19 to 43 yr]) underwent inhalation tests with methacholine (MCh), and hypertonic saline combined with sputum induction. Dyspnea was assessed by Borg and Visual Analogue Scale (VAS), plotted against the percent fall in FEV1, and expressed as the slope of the regression line (Slope-Borg and Slope-VAS). The brittle and stable asthmatics had poorer perception than patients with mild asthma (Slope-Borg [p = 0.036], Slope-VAS [p < 0.001] for MCh). In patients with brittle asthma the perception was less as compared with severe-stable asthma (Slope-Borg for MCh: p = 0.05). In the severe asthmatics there was an inverse correlation between sputum eosinophilia and Slope-Borg and Slope-VAS (R = -0.55, p = 0. 002 and R = -0.37, p = 0.049), whereas this correlation was a positive one in the mild asthmatics (R = 0.79, p = 0.012 and R = 0. 67, p = 0.05). In conclusion, patients with severe asthma, particularly those with recurrent exacerbations, have blunted perception of dyspnea, which is related to the degree of sputum eosinophilia. This suggests that increased sputum eosinophilia is an indicator of clinical instabililty, and that eosinophilic airways inflammation might affect dyspnea perception in severe asthma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9769272     DOI: 10.1164/ajrccm.158.4.9710087

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  18 in total

Review 1.  Association of sputum parameters with clinical and functional measurements in asthma.

Authors:  E Rosi; G Scano
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

2.  Perception of airway narrowing during reduction of inhaled corticosteroids and asthma exacerbation.

Authors:  C M Salome; J D Leuppi; R Freed; G B Marks
Journal:  Thorax       Date:  2003-12       Impact factor: 9.139

3.  Dysfunctional breathing in asthma: is it common, identifiable and correctable?

Authors:  M D L Morgan
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

4.  Triggers and monitoring in intelligent personal health record.

Authors:  Gang Luo
Journal:  J Med Syst       Date:  2011-09-23       Impact factor: 4.460

5.  Incentive spirometry as a means to score breathlessness.

Authors:  Li-Cher Loh; Pek-Ngor Teh; Sree Raman; Pillai Vijayasingham; Tarmizi Thayaparan
Journal:  Malays J Med Sci       Date:  2005-01

6.  Hyperventilation and asymptomatic chronic asthma.

Authors:  C A Osborne; B J O'Connor; A Lewis; V Kanabar; W N Gardner
Journal:  Thorax       Date:  2000-12       Impact factor: 9.139

Review 7.  Perception of airway obstruction and airway inflammation in asthma: a review.

Authors:  Elisabetta Rosi; Loredana Stendardi; Barbara Binazzi; Giorgio Scano
Journal:  Lung       Date:  2006 Sep-Oct       Impact factor: 2.584

8.  Differing reports of asthma symptoms in African Americans and Caucasians.

Authors:  D Scott Trochtenberg; Rhonda BeLue; Sharon Piphus; Niketa Washington
Journal:  J Asthma       Date:  2008-03       Impact factor: 2.515

9.  Descriptors and perception of dyspnea in African-American asthmatics.

Authors:  D Scott Trochtenberg; Rhonda BeLue
Journal:  J Asthma       Date:  2007-12       Impact factor: 2.515

10.  Heterogeneity of perception of symptoms in patients with asthma.

Authors:  Akihiko Ohwada; Katsuhiko Sato
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.